News & Events

Information for those wishing to make a donation

At the Taubman Institute, we have been deeply touched by the calls and e-mails from individuals wishing to honor the life and legacy of A. Alfred Taubman through a donation to support lifesaving medical research.

To make a gift online via credit card, simply click here. 

Checks made payable to the University of Michigan may be mailed to:

A. Alfred Taubman Medical Research Institute
109 Zina Pitcher Place
5017 A. Alfred Taubman Biomedical Science Research Bldg.
Ann Arbor, MI 48109-2200

For assistance, please phone: 734-615-7282

If you are interested in making a major gift to support the Emerging Scholars Program, please contact development officer Maria Muller at  734-355-5233  or This email address is being protected from spambots. You need JavaScript enabled to view it. .

The University of Michigan has 501(c)(3) non-profit tax exempt status; our federal tax ID number is 38-6006309.

Our deepest thanks to all who have extended condolences and memorial tributes on the passing of Mr. Taubman.

 

Funeral arrangements for Mr. Taubman

A service for Mr. Taubman will be held at 11 a.m. at Congregation Shaarey Zedek in Southfield, Mich. 

Arrangements are being handled by The Ira Kaufman Chapel.

Please click here for more information about the live streaming of the services on the Kaufman Chapel website.

Taubman Scholars reflect on A. Alfred Taubman

The mission of the Taubman Institute is to support eminent clinician-scientists — doctors taking on the dual role of physician and laboratory researcher in their zeal to speed new cures and treatments to their patients.  

Taubman Scholar grants allow these dedicated healers the freedom they need to pursue “high-risk, high-reward” science that in a few short years has led to more than 50 human clinical trials of new therapies.

Here, the Taubman Scholars share their reflections on the extraordinary contributions that Alfred Taubman has made to the future of medical science.

The Taubman Institute that is the refection of Mr. Taubman’s unselfishness has enabled a line of scientific inquiry that would not have occurred otherwise. Mr. Taubman and I had two one-on-one conversations, the first when he came to my office to consider my application as a Scholar, and the second more recently. On both occasions he inspired me with his determination, forward looking approach and kindness. I am forever grateful to have had the chance to know him and his family.

 

Thomas Gardner, M.D., M.S.
Healthy Eyes Taubman Scholar
Professor, Ophthalmology and Visual Sciences
Professor, Molecular and Integrative Physiology
Director, Juvenile Diabetes Foundation Retinopathy Center

 

 

To me, the Taubman Institute represents a celebration of a life well-lived, and a deep desire to make a difference for the good of the world. Mr. Taubman was always a visionary, striving to invent and reinvent. He was amazingly successful at that. I’m fortunate to have made Mr. Taubman's acquaintance, and am very proud to be part of the Taubman Institute.

 

Alon Kahana, M.D., Ph.D.
Assistant Professor and Helmut F. Stern Professor
Ophthalmology and Visual Sciences
Kellogg Eye Center, University of Michigan

 

 

When one has an inspiration to further high risk, high reward translational science, and operationalizes it, it has the most meaning for those patients who ultimately benefit from that inspiration and kindness. Mr. Taubman’s inspiration has motivated young as well as established scientists to heed his call to provide help for those afflicted with disease. The world is in a better place through that inspiration.

 

John M. Carethers, M.D.
John G. Searle Professor and Chair
Department of Internal Medicine

 

 

Mr. Taubman supported the research in my laboratory. He took the time to listen to me and to encourage the progress we were making towards better treatments for people who were infected with HIV. He helped me and the trainees in my lab. I am grateful for this and I am honored to have known him. He will be greatly missed.

 

Kathleen Collins, M.D., Ph.D.
Internal Medicine Collegiate Professor of HIV Research
Professor of Internal Medicine
Professor of Microbiology and Immunology

 

 

Alfred was a great and inspiring man. The establishment of the Taubman Institute was grounded in his desire to end human suffering from diseases including dementia, Lou Gehrig's disease, and childhood cancer. I am grateful to have met him. His kindness and passion for science to improve the human condition were both inspiring and a great motivator for me and my research team.

 

Valerie P. Castle, M.D.
Chair, Pediatrics and Communicable Diseases
Ravitz Foundation Professor of Pediatrics and Communicable Diseases

Professor of Pediatric Hematology/Oncology

 

 

I got to know Mr. Taubman about four years ago when I was being considered to become a Taubman Scholar. I showed him our work in treating liver tumors with a unique radiation therapy approach and was amazed at how quickly he understood the concepts and of the quality of the questions he asked. He was 100 percent on target and very perceptive.

 

In addition to his well-known passion for architecture and for building, he had a keen mind and depth of insight well beyond what I would expect from the average intelligent lay person. Maybe it is because radiation therapy depends on three dimensional thinking, and his "architectural brain" was already trained that way.

He will be missed.

 

Theodore S Lawrence, M.D., Ph.D., FASCO, FASTRO
Max S. Wicha M.D. Distinguished Professor of Oncology
Director, University of Michigan Comprehensive Cancer Center
Chair, Department of Radiation Oncology

 

 

Alfred Taubman's vision in creating the Taubman Medical Institute has been transformative. His generosity has allowed us to form the collaborations and pursue the type of high risk-high reward research that is critical to advance our field.

 

Srijan Sen, M.D., Ph.D.
Assistant Professor
Psychiatry, Neuroscience and Bioinformatics
Molecular and Behavioral Neuroscience Institute

 

 

It is difficult to convey what Mr. Taubman did for me, personally, to push forward new lines of research in my own lab. I was fortunate to have lunch with Mr. Taubman last year at his office, where his curiosity about many things, including science, was on full display – impressive indeed! I saw firsthand his deep commitment to spur Taubman Scholars toward new insights into human disease and, from that knowledge, better therapies. Mr. Taubman made, and will continue to make, a major impact on what many of us do in our labs and at the bedside.

 

Henry L. Paulson, M.D., Ph.D.
Professor, Department of Neurology
Lucille Groff Professor of Neurology

 

 

Some men and women achieve immortality. It may be through the memory and deeds of their children. It may be through the legacy of their work. It may be through the achievements of others that they have made possible.

 

A. Alfred Taubman, mentor, patron, and friend to so many of us, achieves immortality through each of these. Through the A. Alfred Taubman Medical Institute, which Alfred and his family founded and support, and in which I am a scholar, physician-scientists are finding meaningful treatments for the most difficult neurological diseases of our time—ALS or Lou Gehrig’s disease, Alzheimer’s disease, Parkinson’s disease, spinal cord injury and stroke.

 

Ongoing initiatives, which helped and continue to help scores of patients with terrible disease, were always front-and-center in our conversations. Alfred’s insightful and incisive questions, his encouragement and support to break through barriers and challenges, and his shared delight in what we have achieved, never failed to inspire. He uniquely provided both the faith that makes the seemingly impossible possible and the critical resources to make it happen.

 

He has been a giant, on whose shoulders we can all stand. I will miss Alfred as a mentor and as a friend, I will remember him for his curiosity and his warmth and his unwavering support, and my patients will thank him for all that he has made possible, for the rest of our days. For who he has been and for what he has done, A. Alfred Taubman is truly immortal.

 

Parag G. Patil, M.D., Ph.D.
Assistant Professor of Neurosurgery, Neurology, Anesthesiology, and Biomedical Engineering

 

I am deeply saddened by our loss of Mr. Taubman. Since the beginning of my academic career in medicine he has inspired me in countless ways. The admiration that I have for him lies not only in his overwhelming support of me and my lab efforts, but by his compassion and his unyielding desire to change to world. I will miss him dearly. His legacy will live on through us all.

 Erika Newman, MD, FAAP, FACS
Assistant Professor of Pediatric Surgery
Surgical Director, Mott Solid Tumor Oncology Program (MSTOP)

 

His vision and tremendous generosity for supporting research has touched many, including me. He has left an indelible legacy here at Michigan and I will personally remember him for his wit, curiosity and genuine interest in knowing about my own and others research. An irreplaceable loss, my heart and prayers go out to his family and loved ones.

 

Pavan Reddy, M.D.

Moshe Talpaz Professor of Translational Oncology

Professor of Medicine

Co-Director, Hematological Malignancies and BMT Program

Associate Division Chief, Hematology-Oncology

 

 

 

The support from Mr. Tubman and the Emerging Scholars Program has been instrumental in my ability to advance translational research and I am so greatful for his amazing generosity.  He will be sorely missed, but his vision for research advancement will live on through all those whom his gifts have touched.

 Katherine A. Gallagher, M.D.

Assistant Professor of Surgery

 

 

 

What I felt after all of my interactions with Alfred was his joy of accomplishment.  He always seemed to have such a positive attitude.   Whether he was talking about his career or the next thing he was going to do in life, there wasn’t a doubt in his mind that he couldn’t do it.  It was infectious. 

Charles F. Burant, M.D., Ph.D.

Dr. Robert C. and Veronica Atkins Professor of Metabolism
Professor of Internal Medicine
Professor of Molecular and Integrative Physiology

 

 

Mr. Taubman was an extraordinary pioneer, innovator and visionary and I had the good fortune to first meet him in 2011 when I joined the Taubman Medical Research Institute as an Emerging Scholar.  Of the discussions I’ve had with Mr. Taubman over the years, several of which incidentally were on salmon fishing in my home country Iceland, I have always been struck by his inquisitive mind and openness.  Through his vision the work that he has enabled at the Taubman Medical Research Institute will have a world-wide impact in the years and decades to come. Thank you Mr. Taubman for all you have done

Johann Gudjonsson, M.D., Ph.D.

Assistant Professor, Dermatology

 

 

Mr. Taubman’s generosity and commitment to the University of Michigan has impacted my every phase of my career, beginning as a medical student studying in the Taubman Library or seeing patients in the Taubman Health Care Center to starting my laboratory in the A. Alfred Taubman Basic Sciences Research Building. More recently, being named the A. Alfred Taubman Emerging Scholar allowed me to get to know Mr. Taubman and experience firsthand his commitment to the University, young clinician scientists, and translational research that can directly impact patients.

 

 

 Scott Tomlins, M.D., Ph.D.

The A. Alfred Taubman Emerging Scholar

Assistant Professor, Pathology

 

 

Dr. Eva Feldman commemorates Alfred Taubman

A. Alfred Taubman, one of the world's leading champions of bold approaches to medical research, passed away at age 91 on April 18, 2015.  One of his enduring legacies will be the groundbreaking work of the clincian-scientists whose work has been accelaterated by the charge from the Taubman Institute to use unrestricted financial grants to follow their hunches and establish new paradigms in the development of cures and diseases for mankind's most difficult diseases.

“All of us who knew and worked with Mr. Taubman are deeply grieving his passing. But at the same time we are grateful for his extreme generosity, wise leadership and limitless ability to make change happen,” said Eva L. Feldman, M.D., Ph.D., director of the A. Alfred Taubman Medical Research Institute at the University of Michigan.

“The source of Mr. Taubman’s greatness lies in his bold, visionary thinking and his willingness to take bold risks that changed conventional thinking in every area he touched. The immeasurable benefits his work will bring to future generations will be the legacy of his passion, his inspiration and his unmatched ability to achieve grand results.”

 

 

University of Michigan Statement on the passing of A. Alfred Taubman

Statement from Mark S. Schlissel, M.D., Ph.D., president of the University of Michigan

The University of Michigan family was saddened to learn of the passing of A. Alfred Taubman. We have lost a dear friend and educational partner, one of the genuine leaders and best.

Our hearts go out to his family, friends, loved ones, and all those he has touched with his considerable generosity and commitment to a better University of Michigan.

The University of Michigan – and the opportunities we provide to our students – would not be the same without Mr. Taubman. He valued state-of-the-art facilities for teaching, research and patient care, and he was always mindful of supporting the activities that take place inside the university and the buildings that bear his name. He provided scholarships to our students, enhanced the way we teach architecture and urban planning, and gave our faculty the opportunity to launch unparalleled medical research initiatives.

Mr. Taubman’s legacy at the University of Michigan will forever reflect his generosity, impact, and passion for advancing opportunities for our campus, its students and the health and well-being of all members of society. His strong support of the University of Michigan during his life will be further augmented by the provisions he made in his will for the university’s future.

He was a great man– successful, generous and warm. But he also was someone who held all those around him to high standards. He helped drive excellence at Michigan not just through his philanthropy, but by the advice he gave to multiple presidents and the fact that he held us to account to get the very most out of everything we did.

Our entire community will deeply miss Mr. Taubman and his commitment to our campus and students.

Two CME credits offered at Taubman Emerging Scholars Symposium

2nd Annual Taubman Emerging Scholars Symposium

Six talented young leaders of the next generation of medical researchers will speak April 27 at the 2nd Annual Emerging Scholars Symposium of the A. Alfred Taubman Medical Research Institute. The symposium will take place from 10 a.m. to noon at the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building.

These groundbreaking clinician-scientists on the faculty of the University of Michigan Medical School  are making remarkable strides toward treatments for life-altering conditions like prostate cancer, wounds that won't heal, inflammatory skin conditions, deteriorating joints, vision loss and neurological diseases.

Physicians attending may be eligible for 2 CME credits per the following criteria:
 
 
Program objectives:
This symposium will summarize recently-published peer-reviewed research by the Emerging Scholars of the A. Alfred Taubman Medical Research Institute. New information regarding the treatment of various conditions will be presented by the clinician-scientists who authored the research. 
 
At the conclusion of the seminar, participants will be able to implement:
 Better approaches in the treatment of patients with joint damage
 New approaches in the use of diagnostic imaging for patients with neurodegenerative diseases
 Approaches to the management of impaired wound healing in patients with diabetes
 The latest knowledge regarding inflammatory skin diseases
 New approaches to muscle regeneration in patients ophthalmology
 The latest knowledge regarding the genomics of prostate cancer

Who should attend:
The symposium is open to University of Michigan clinicians and research scientists, as well as other primary care practitioners and public health scholars interested in the most recent discovery regarding these prevalent diseases.

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

2nd Annual Taubman Emerging Scholars Symposium April 27

Six talented young leaders of the next generation of medical researchers will speak April 27 at the 2nd Annual Emerging Scholars Symposium of the A. Alfred Taubman Medical Research Institute. 

These groundbreaking clinician-scientists on the faculty of the University of Michigan Medical School  are making remarkable strides toward treatments for life-altering conditions like prostate cancer, wounds that won't heal, inflammatory skin conditions, deteriorating joints, vision loss and neurological diseases. 

Their work is made possible in part by grants from the Taubman Instittue's Emerging Scholars Program.  Aimed at launching the laboratories of U-M's best and brightest young doctors, these grants of $50,000 per year for three years help ensure that we all will benefit from the next generation of medical breakthroughs. 

In just a few short years, Taubman Emerging Scholars have initiated nine human clinical trials of new treatments in fields ranging from cancer to inflammatory diseases.  With 16 Emerging Scholars now being supported – and two dozen more worthy candidates vetted and ready for funding – it’s a program that aims for, and achieves, fast results for patients who can’t wait.

All are welcome to attend the symposium; no registration is required.  2 CME credits are available for qualifying physician attendees.

Featured speakers are:

Asheesh Bedi, M.D.  ~ "Challenges and advances in joint preservation of the hip."

Bradley Foerster, M.D., Ph.D.  ~ "Capturing disease and guiding treatments for ALS through imaging."

Katherine Gallagher, M.D.  ~ "Histone methylation changes in myeloid cells influence inflammation and impair wound healing in type II diabetes."

Johann Gudjonsson, M.D., Ph.D.  ~ "Psoriasis – genetics and associated diseases."

Alon Kahana, M.D., Ph.D. ~ "Muscle regeneration and cellular reprogramming: the value of going the wrong way!"

Scott Tomlins, M.D., Ph.D. ~ "Translating the cancer genome to the clinic."

 

Details:

2nd Annual Emerging Scholars Symposium

10 a.m. - noon
D. Dan and Betty Kahn Auditorium
A. Alfred Taubman Biomedical Science Research Building
109 Zina Pitcher Place, Ann Arbor, MI  48109
No registration required ~ All welcome

Coffee and pastries served at 9:30 a.m.

 

CME credit may be available for qualifying physician attendees:  

Program objectives:

This symposium will summarize recently-published peer-reviewed research by the Emerging Scholars of the A. Alfred Taubman Medical Research Institute. New information regarding the treatment of various conditions will be presented by the clinician-scientists who authored the research. 

At the conclusion of the seminar, participants will be able to implement:
 Better approaches in the treatment of patients with joint damage

 New approaches in the use of diagnostic imaging for patients with neurodegenerative diseases

 Approaches to the management of impaired wound healing in patients with diabetes

 The latest knowledge regarding inflammatory skin diseases

 New approaches to muscle regeneration in patients ophthalmology

 The latest knowledge regarding the genomics of prostate cancer

Who should attend:
The symposium is open to University of Michigan clinicians and research scientists, as well as other primary care practitioners and public health scholars interested in the most recent discovery regarding these prevalent diseases.

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Cures Are an Art Form: Party for medical research, May 12 in Detroit

For the second year in a row, the scholars of the Taubman Institute have joined forces with leading contemporary artists in a fascinating project that will culminate this month in a gala fundraising auction to benefit high-risk, high-reward medical research by some of the most cutting-edge young scientists at the University of Michigan.

The institute's eminent physician-researchers – the thought leaders in areas like cancer, cardiovascular health, ALS and more – have teamed up with creative virtuosos for mind-bending conversations about the intersection of discovery and creativity in their respective fields. The resulting one-of-a-kind creations will be auctioned in May at the Detroit Institute of Arts.

Supporters can take a sneak peak at the artwork, and mingle with the artists and scientists, at "Cures are An Art Form," the preview party May 12 in Detroit's historic Majestic Theater. 

Join us Tuesday, May 12, to party for a worthy cause!

Location: Majestic Theater, 4120 Woodward Ave, Detroit

Door time: 6 p.m.

Open bar (beer & wine) 6-8 p.m.

Cash bar 8-10 p.m.

Light refreshments served

Entertainment by Ethan Davidson

Tickets: $50  ~ Purchase now via ticketweb

Proceeds from "Cures Are an Art Form" and the upcoming May 14 fundraising auction at the DIA (open to ticketed guests only) will fund the Taubman Institute's Emerging Scholars grants.  Aimed at launching U-M's best and brightest young doctors into the dual role of physician and research scientists, these grants of $50,000 per year for three years help launch the next generation of medical breakthroughs.  In just a few short years, Taubman Emerging Scholars have initated nine human clinical trials of new treatments in fields ranging from cancer to inflammatory diseases. 

To view a video about the Emerging Scholars Program, click here. 

 

Stem cell expert Dr. Tamir Ben-Hur to deliver grand rounds April 1

Tamir Ben-Hur, M.D., Ph.D, a leading researcher of regenerative therapies for multiple sclerosis, will speak in Ann Arbor on April 1 as a guest of the Taubman Institute's Visiting Professor Lecture Series.

Dr. Ben-Hur chairs the neurology department at Hadassah-Hebrew University Medical Center in Israel.  He also is Professor of Neurology and holds the Israel S. Wechsler Chair in Neurology at the university's medical school.

His research projects focus on the therapeutic properties of stem cells, and their bilateral interactions with the nervous system in normal and pathologic states. His clinical interests are in general Neurology, and Neuro-immunology. He has published numerous papers in basic and clinical neurosciences, and serves on the editorial board of several neuroscience journals.

On April 1 at 10:30 a.m., Dr. Ben-Hur will present "Towards Regenerative Therapy in Multiple  Sclerosis: Implications for Neurodegenerative Diseases” in the Danto Auditorium at the U-M Health System's Cardiovascular Center.

Taubman Scholar Theodore S. Lawrence tapped as new cancer center director

Taubman Scholar Theodore S. Lawrence, M.D., Ph.D., has been named the director of the University of Michigan Comprehensive Cancer Center. The appointment was approved Feb. 19 by the University of Michigan Board of Regents.

Lawrence succeeds Max S. Wicha, M.D., who founded the Cancer Center 27 years ago.  Wicha also is a Founding Taubman Scholar and current deputy director of the Taubman Institute.

“This is a tremendous program with talented and dedicated faculty and staff, a terrific research infrastructure and superb core facilities,” says Lawrence, who will assume the title of Max S. Wicha, M.D., Distinguished Professor of Oncology. He is also chair of radiation oncology in the University of Michigan Medical School.

Lawrence cites the Cancer Center’s strength in precision medicine, drug discovery and health policy research as well as opportunities to deepen clinical and translational research efforts.

The center’s “comprehensive” status is designated by the National Cancer Institute and reflects participation in cancer basic, clinical, and population sciences research, with strong interactions among those areas. A center must also provide public information, education and outreach programs. U-M is one of two comprehensive cancer centers in Michigan and one of 41 across the country.

“Michigan has been the epicenter of many global advances in cancer research and care. As patients, families and the scientific community look to us for the next breakthroughs, we are fortunate to have the expertise of an established leader of Dr. Lawrence’s caliber to guide the Cancer Center into a very promising future,” says James O. Woolliscroft, M.D., dean of the U-M Medical School and Lyle C. Roll Professor of Medicine.

In addition to continuing to advance the Cancer Center’s research excellence, Lawrence plans to grow the center’s statewide presence as part of an effort to bring cancer care closer to home.

“The vast majority of cancer care can be done in the community with strong partnerships. We want to create more of those partnerships to allow more patients in our state to receive the right care in the right place,” Lawrence says.

Lawrence’s laboratory interests are focused on chemotherapeutic and molecularly targeted radiosensitizers. His clinical research combines these laboratory studies with conformal radiation guided by metabolic and functional imaging to treat patients with pancreatic and other gastrointestinal cancers. Lawrence expects to continue patient care and research activities as Cancer Center director. He will continue to serve as chair of radiation oncology as well.

In addition, Lawrence has served in leadership positions in many of the most prestigious oncology societies, including the American Society of Radiation Oncology, the American Society of Clinical Oncology, the Radiation Oncology Institute, the Society of Chairs of Radiation Oncology, and both the Board of Scientific Councilors and the Board of Scientific Advisors of the National Cancer Institute. He is a member of the Institute of Medicine of the National Academy of Sciences. He has received the ASTRO Gold Medal, the highest award conferred by the society, an ASCO Statesman Award, and the 2014 Outstanding Investigator Award from the Radiological Society of North America.

Lawrence joined the faculty of the University of Michigan in 1987, following a fellowship in medical oncology and a residency in radiation oncology at the National Cancer Institute. He received his research degree in cell biology from the Rockefeller University in New York, followed by his medical degree from Cornell University and an internal medicine residency at Stanford University.

Subcategories

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift